跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,726 条关于
“UTRxM1-18”
全部
7,726
临床试验
3,188
药物
603
机构
115
资讯
3,820
去年
UTR Therapeutics Publishes Preclinical Data for First-in-Class c-MYC RNA Therapeutic UTRxM1-18
去年
UTR Therapeutics Submits IND for Novel mRNA-Destabilizing Drug Targeting c-MYC in Multiple Cancers
去年
Vabysmo Shows Vision Improvement in Underrepresented DME Populations in ELEVATUM Study
去年
Benitec BioPharma's Gene Therapy Shows Promising Results in Oculopharyngeal Muscular Dystrophy Trial
去年
AAO 2024: 3D-Printed Glasses, ANX007 for Geographic Atrophy, and Cataract Surgery Risks Highlighted
去年
FDA Issues Complete Response Letter for Astellas' Avacincaptad Pegol; Aldeyra's Reproxalap NDA Accepted
2年前
Recursion Pharmaceuticals Announces Seven Clinical Readouts Expected Within 18 Months
去年
Remedy Plan Therapeutics Secures $18 Million to Advance Novel NAMPT Inhibitor for AML and MDS Treatment
去年
FDA Issues Complete Response Letter for Astellas' IZERVAY and Accepts Aldeyra's NDA for Reproxalap
上个月
Soter Bio Ends Lobbying Relationship With Tenagrity Solutions After 18 Months
第 1 页,共 382 页
上一页
下一页